Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

FromNEJM Interviews


NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

FromNEJM Interviews

ratings:
Length:
12 minutes
Released:
Feb 8, 2023
Format:
Podcast episode

Description

Dr. Ameet Sarpatwari is an assistant professor of medicine at Harvard Medical School and the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital and Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.S. Tu and A. Sarpatwari. A “Method of Use” to Prevent Generic and Biosimilar Market Entry. N Engl J Med 2023;388:483-485.
Released:
Feb 8, 2023
Format:
Podcast episode

Titles in the series (100)

The New England Journal of Medicine (NEJM) Audio interview RSS feed. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.